Leonteq Securities AG Makes New $1.10 Million Investment in Astera Labs, Inc. $ALAB

Leonteq Securities AG purchased a new position in shares of Astera Labs, Inc. (NASDAQ:ALABFree Report) during the fourth quarter, Holdings Channel reports. The fund purchased 6,618 shares of the company’s stock, valued at approximately $1,101,000.

A number of other large investors also recently added to or reduced their stakes in the company. Perigon Wealth Management LLC lifted its stake in Astera Labs by 6.2% during the fourth quarter. Perigon Wealth Management LLC now owns 1,252 shares of the company’s stock worth $208,000 after purchasing an additional 73 shares in the last quarter. Clearstead Advisors LLC lifted its stake in Astera Labs by 13.6% during the third quarter. Clearstead Advisors LLC now owns 636 shares of the company’s stock worth $125,000 after purchasing an additional 76 shares in the last quarter. Sound Income Strategies LLC lifted its stake in Astera Labs by 9.2% during the fourth quarter. Sound Income Strategies LLC now owns 902 shares of the company’s stock worth $164,000 after purchasing an additional 76 shares in the last quarter. Venturi Wealth Management LLC lifted its stake in Astera Labs by 2.6% during the fourth quarter. Venturi Wealth Management LLC now owns 3,284 shares of the company’s stock worth $546,000 after purchasing an additional 84 shares in the last quarter. Finally, Great Valley Advisor Group Inc. lifted its stake in Astera Labs by 2.2% during the second quarter. Great Valley Advisor Group Inc. now owns 4,119 shares of the company’s stock worth $372,000 after purchasing an additional 90 shares in the last quarter. 60.47% of the stock is currently owned by institutional investors and hedge funds.

Insiders Place Their Bets

In other Astera Labs news, Director Stefan A. Dyckerhoff sold 3,505 shares of the firm’s stock in a transaction on Thursday, May 7th. The stock was sold at an average price of $200.03, for a total value of $701,105.15. Following the sale, the director directly owned 63,639 shares in the company, valued at $12,729,709.17. This trade represents a 5.22% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CEO Jitendra Mohan sold 28,737 shares of the firm’s stock in a transaction on Tuesday, May 19th. The shares were sold at an average price of $249.62, for a total value of $7,173,329.94. Following the completion of the sale, the chief executive officer owned 3,789,232 shares in the company, valued at approximately $945,868,091.84. This represents a 0.75% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders have sold 1,915,461 shares of company stock valued at $358,508,976 in the last three months. Corporate insiders own 12.50% of the company’s stock.

Astera Labs Price Performance

Astera Labs stock opened at $297.84 on Friday. Astera Labs, Inc. has a 1-year low of $84.78 and a 1-year high of $298.36. The stock has a market cap of $51.05 billion, a PE ratio of 201.24, a P/E/G ratio of 3.81 and a beta of 3.35. The stock’s fifty day moving average is $166.74 and its two-hundred day moving average is $158.75.

Astera Labs (NASDAQ:ALABGet Free Report) last posted its quarterly earnings results on Tuesday, May 5th. The company reported $0.61 earnings per share for the quarter, beating analysts’ consensus estimates of $0.54 by $0.07. Astera Labs had a return on equity of 18.49% and a net margin of 26.72%.The company had revenue of $308.36 million for the quarter, compared to analysts’ expectations of $292.19 million. During the same period last year, the firm earned $0.33 earnings per share. Astera Labs’s quarterly revenue was up 93.5% on a year-over-year basis. Astera Labs has set its Q2 2026 guidance at 0.680-0.700 EPS. On average, research analysts expect that Astera Labs, Inc. will post 1.84 earnings per share for the current fiscal year.

Analyst Upgrades and Downgrades

ALAB has been the topic of a number of research reports. Jefferies Financial Group restated a “buy” rating and set a $270.00 price target on shares of Astera Labs in a research note on Wednesday, May 6th. Weiss Ratings upgraded Astera Labs from a “sell (d+)” rating to a “hold (c-)” rating in a research note on Wednesday, May 6th. TD Cowen increased their price objective on Astera Labs from $140.00 to $225.00 and gave the company a “hold” rating in a research note on Wednesday, May 6th. Barclays increased their price objective on Astera Labs from $165.00 to $200.00 and gave the company an “equal weight” rating in a research note on Thursday, May 7th. Finally, JPMorgan Chase & Co. increased their price objective on Astera Labs from $205.00 to $280.00 and gave the company an “overweight” rating in a research note on Wednesday, May 6th. Fourteen investment analysts have rated the stock with a Buy rating and nine have given a Hold rating to the company’s stock. According to data from MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and a consensus price target of $233.75.

Read Our Latest Research Report on Astera Labs

Astera Labs News Roundup

Here are the key news stories impacting Astera Labs this week:

  • Positive Sentiment: Recent analyst coverage has been constructive, including multiple price-target increases and “buy” recommendations, which has helped extend momentum in ALAB shares.
  • Positive Sentiment: Astera Labs has been drawing bullish trader attention, with elevated call option activity and a “Power Inflow” signal suggesting strong buying interest in the stock.
  • Positive Sentiment: The company’s latest earnings beat expectations on both revenue and EPS, supporting the case that AI-related demand is translating into rapid growth.
  • Neutral Sentiment: Several recent insider sales were disclosed by executives, including the CEO, COO, and general counsel. The company said some of the selling was tied to pre-arranged trading plans and tax withholding on equity vesting, which limits the signal as a fundamental warning.

About Astera Labs

(Free Report)

Astera Labs is a fabless semiconductor company that develops connectivity solutions for data center and cloud infrastructure. The firm focuses on addressing signal integrity and link management challenges that arise as server architectures incorporate higher-bandwidth processors and accelerators. Its technology is aimed at improving reliability and performance for high-speed interconnects used in servers, storage systems and compute accelerators.

The company’s product portfolio centers on silicon devices and accompanying firmware and software that enhance and manage high-speed links.

Featured Articles

Want to see what other hedge funds are holding ALAB? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Astera Labs, Inc. (NASDAQ:ALABFree Report).

Institutional Ownership by Quarter for Astera Labs (NASDAQ:ALAB)

Receive News & Ratings for Astera Labs Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Astera Labs and related companies with MarketBeat.com's FREE daily email newsletter.